Article Data

  • Views 2965
  • Dowloads 135

Case Reports

Open Access

Ovarian Burkitt lymphoma: one case report

  • Z. Yang1,†,*,
  • Y. Wang1,†
  • Z. Ma1
  • Y. Zeng1
  • L. Tang1
  • J. Bai1
  • Y. Zeng1

1Department of Obstetrics and Gynecology, Affiliated Hospital of Chengdu University, Chengdu (China)

DOI: 10.12892/ejgo4739.2019 Vol.40,Issue 6,December 2019 pp.1108-1109

Published: 10 December 2019

*Corresponding Author(s): Z. Yang E-mail: yzl1125@163.com

† These authors contributed equally.

PDF (303.4 kB) View Full-text

Abstract

A 12-year-old female patient was admitted to this hospital on March 19, 2015, because of lower abdominal pain lasting longer than one month. She had an appendectomy in a local hospital two months before admission. Two weeks after this operation, she began ex-periencing intermittent idiopathic pain in the lower abdomen, which progressively worsened. After admission, the physical examination, B-ultrasound, and enhanced CT revealed several lumpy shadows of mixed density in the pelvic and celiac areas, with a maximum lesion of 14.7×10.5 cm and unclear borders. The concentration of carbohydrate antigen 125 (CA-125) was significantly elevated. Surgery and rapid pathology confirmed the diagnosis of a left ovarian malignant tumor, and routine pathology further indicated ovarian Burkitt lym-phoma

Keywords

Ovarian Burkitt lymphoma; Diagnosis; Treatment.

Cite and Share

Z. Yang, Y. Wang, Z. Ma, Y. Zeng, L. Tang, J. Bai, Y. Zeng. Ovarian Burkitt lymphoma: one case report. European Journal of Gynaecological Oncology. 2019; 40(6): 1108-1109. doi: 10.12892/ejgo4739.2019

References

[1] Bollard CM, Lim MS, Gross TG, Committee COGN-HL. Children’s Oncology Group’s 2013 blueprint for research: non-Hodgkin lym-phoma. Pediatr. Blood Cancer, 2013, 60, 979.

[2] Wildes T.M., Farrington L., Yeung C., Harrington A.M., Foyil K.V., Liu J., et al.: “Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers”. Ther. Adv. Hematol., 2014, 5, 3.

[3] Xie Xing, Gou Wenli (eds). Obstetrics and Gynecology. People’s Medical Publishing House, 2013, 321.

[4] Muñoz Martín A.J., Pérez Fernández R., Viñuela Beneítez M.C., Martínez Marín V., Marquéz-Rodas I., Sabin Domínguez P., García Alfonso P.: “Primary ovarian Burkitt lymphoma”. Clin. Transl. Oncol., 2008, 10, 673.

[5] Cui T., Wang C., He H., Shi G., Hu L.: “A rare case of ovarian Burkitt lymphoma associated tumor lysis syndrome”. Eur. J. Gynaecol. Oncol., 2010, 31, 209.

Submission Turnaround Time

Top